Scitaris

Meet with Scitaris at #BIOEurope in Stockholm next month! Reach out to learn more about our strategy & BD&L support via the PartneringOne platform or e-mail us directly to office@scitaris.com. Our founding partner team Jonathan Vonnemann, Sarah Oelsner, Graham Scholefield and Nick Groenewoud are looking forward to catching up.

Our Scitaris colleague Catarina Martins Costa has been busy over the past couple days scouting exciting programs and upcoming trends in Rheumatology / I&I at #ACR2024 in Washington D.C.

🌐 Professional Development Opportunity! 🌐 We're excited to invite you to our next "In CONTACT with" session featuring Scitaris, on November 27, 2024. Join us for a dynamic workshop titled "Everyday life as a consultant: Evaluate an early-stage drug opportunity!" led by Michael Gropp, PhD, a consultant at Scitaris. This interactive session will provide insights into the scientific validation of drug candidates and the strategic business considerations in clinical drug development. 🗓 Date: Wednesday, November 27, 2024 ⏰ Time: 6 PM CET 📍 Location: Communication Center, DKFZ (Seminar Room K1/K2) and online 🔗 Zoom Details: Meeting ID: 850 3912 6721 Passcode: ICW-Scita Link: https://lnkd.in/e2-2exSk Don't miss this opportunity to delve into the world of biotech consulting and enhance your understanding of the pharmaceutical industry's challenges and strategies. Looking forward to an enriching session filled with insights and networking opportunities! For more information, visit our page: https://lnkd.in/eF3UNM4e #BioContact2024 #Scitaris #CareerDevelopment #BiotechConsulting #PharmaceuticalIndustry #NetworkingEvent #ProfessionalGrowth

Scitaris continues to grow and we are very excited to welcome Vera Kleene and Thomas Hutschalik to the team. Vera Kleene joins us with a strong background in Chemistry and Biochemistry where she obtained her degrees from Ludwig-Maximilians-Universität München. During multiple research stays at Imperial College London, University of St Andrews and Griffith Institute for Drug Discovery in Brisbane, Australia, Vera gained a wide spectrum of insights in immunology, Oncology and Alzheimer's modelling. She obtainer her Ph.D. from Biomedical Center (BMC) LMU Munich where she used mass spectrometry to investigate epigenetic mechanisms, specifically the coupling of metabolism and histone modification as well as interference with chromatin assembly by small molecule intervention. Thomas Hutschalik also has a multidisciplinary background in Medical Engineering and Biomedical Technology from his undergrad degrees obtained from University of Tuebingen. His EU-funded, industry-driven PhD project he conducted at Ncardia in collaboration with Maastricht University, which provids him with extensive insights in the fields of human induced pluripotent stem cells, cardiac diseases, immunology and tissue engineering. In addition, Thomas has worked at Fresenius Medical Care and was a blue book trainee at the European Commission. Excited to finish the final quarter of 2024 together with the team! #scitaris #growth #biopharma #strategy . 

Day 2 for the Scitaris team at #bioeurope24 in Stockholm. Drop by our booth located between Novartis (best conference coffee) and Evotec!

Our autumn UK University tour continues - meet Scitaris at the University of Cambridge Life Sciences Fair 2024. Our amazing team on-site, Sheng Yang Lee and Karan Bali, will answer all your questions about the firm and their job as an R&D strategy consultant in biopharma. We still have several PhD entry-level positions open with flexible starting dates throughout 2025!

Meet Sheng Yang Lee and Karan Bali today until 2:30pm at University of Oxford and find out more about career opportunities at Scitaris

Meet Dr Sheng Yang Lee and Karan Bali, PhD at University of Oxford and find out more about career opportunities at Scitaris.

Today we are happy to introduce two Scitaris team members again. Riccardo Di Vincenzo holds degrees in Biotechnology and Biomedical Sciences from University of Cambridge and University of Amsterdam. During is PhD & PostDoc he focused on developing novel vaccine strategies against HIV at FAU Erlangen-Nürnberg and later on in collaboration with the Max Planck Institute for the Science of Light, worked on creating a biosensor for detecting antigen-specific antibodies in patients' sera at the single molecule level. Beyond academia, Riccardo manages a portfolio of real estate properties and has contributed to the development of a go-to-market strategy for a start-up focused on a diabetes monitoring device. Mariia Zeziulia obtained her undergrad from Taras Shevchenko National University of Kyiv which inspired her to pursue her research focus around ion channel biophysics, particularly by the role of ion channels in healthy and disordered nervous system function. This brought her to join the Max Planck Society/ The University of Göttingen as well as the Max Delbrück Center & Leibniz Research Institute for Molecular Pharmacology for her PhD uncovering the role of the acid-activated chloride channel in the resolution of intracellular organelles and exploring the function of the volume-regulated anion channel (VRAC) in hearing. Excited to go into the final quarter of 2024 together with the team! #team #scitaris #strategy #biopharma